Free Trial
NASDAQ:TOI

Oncology Institute (TOI) Stock Price, News & Analysis

Oncology Institute logo
$3.46 -0.03 (-0.86%)
Closing price 04:00 PM Eastern
Extended Trading
$3.49 +0.03 (+0.87%)
As of 05:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Oncology Institute Stock (NASDAQ:TOI)

Key Stats

Today's Range
$3.41
$3.55
50-Day Range
$2.05
$4.28
52-Week Range
$0.13
$4.50
Volume
951,560 shs
Average Volume
1.47 million shs
Market Capitalization
$323.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

Oncology Institute Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

TOI MarketRank™: 

Oncology Institute scored higher than 52% of companies evaluated by MarketBeat, and ranked 534th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Oncology Institute has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Oncology Institute has only been the subject of 2 research reports in the past 90 days.

  • Read more about Oncology Institute's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oncology Institute is -5.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oncology Institute is -5.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Oncology Institute's valuation and earnings.
  • Percentage of Shares Shorted

    12.11% of the float of Oncology Institute has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncology Institute has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncology Institute has recently decreased by 23.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Oncology Institute does not currently pay a dividend.

  • Dividend Growth

    Oncology Institute does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.11% of the float of Oncology Institute has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncology Institute has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncology Institute has recently decreased by 23.08%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Oncology Institute has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Oncology Institute this week, compared to 2 articles on an average week.
  • Search Interest

    Only 3 people have searched for TOI on MarketBeat in the last 30 days. This is a decrease of -81% compared to the previous 30 days.
  • MarketBeat Follows

    18 people have added Oncology Institute to their MarketBeat watchlist in the last 30 days. This is an increase of 800% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oncology Institute insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,959,013.00 in company stock.

  • Percentage Held by Insiders

    Only 8.50% of the stock of Oncology Institute is held by insiders.

  • Percentage Held by Institutions

    Only 36.86% of the stock of Oncology Institute is held by institutions.

  • Read more about Oncology Institute's insider trading history.
Receive TOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TOI Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
See More Headlines

TOI Stock Analysis - Frequently Asked Questions

Oncology Institute's stock was trading at $0.3090 at the beginning of 2025. Since then, TOI stock has increased by 1,019.7% and is now trading at $3.46.

The Oncology Institute, Inc. (NASDAQ:TOI) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.18) earnings per share (EPS) for the quarter. The firm earned $104.41 million during the quarter. Oncology Institute had a negative net margin of 14.26% and a negative trailing twelve-month return on equity of 1,527.21%.
Read the conference call transcript
.

Oncology Institute's top institutional shareholders include Tiff Advisory Services LLC (4.07%), Balyasny Asset Management L.P. (2.82%), Marshall Wace LLP (1.66%) and Geode Capital Management LLC (1.43%). Insiders that own company stock include Growth I LP M33, Daniel Virnich, Brad Hively, Richard A Barasch, Mark L Pacala, Matthew P Miller, Yale Podnos, Mohit Kaushal and Havencrest Healthcare Partners.
View institutional ownership trends
.

Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncology Institute investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Arista Networks (ANET), Adobe (ADBE), AppLovin (APP) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/14/2025
Today
8/27/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:TOI
CIK
1799191
Fax
N/A
Employees
660
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$6.00
Potential Upside/Downside
+99.0%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.68)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.66 million
Net Margins
-14.26%
Pretax Margin
-15.56%
Return on Equity
-1,527.21%
Return on Assets
-34.25%

Debt

Debt-to-Equity Ratio
14.58
Current Ratio
1.62
Quick Ratio
1.37

Sales & Book Value

Annual Sales
$424.38 million
Price / Sales
0.77
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.10) per share
Price / Book
-35.17

Miscellaneous

Outstanding Shares
93,505,000
Free Float
85,557,000
Market Cap
$328.86 million
Optionable
Not Optionable
Beta
0.08
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:TOI) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners